Novartis AG Common Stock (NVS)

Other Income/Expenses (Net)

-$1.47B

TTM · Period ending: · USD

NVS logo

NVS Other Income/Expenses (Net)

Latest reported-$1.47B
NVS TTM Other Income/Expenses (Net) ($774.00M → -$1.47B)
High-resolution chart · PNG

NVS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
2,027,000,000
2,031,000,000
774,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.